Olfactory cleft mucus proteins associated with olfactory dysfunction in a cohort without chronic rhinosinusitis

Background Olfactory dysfunction (OD) is a common problem, affecting up to 20% of the general population. Previous studies identified olfactory cleft mucus proteins associated with OD in chronic rhinosinusitis (CRS) but not in a healthy population. In this study we aimed to identify olfactory cleft...

Full description

Saved in:
Bibliographic Details
Published inInternational forum of allergy & rhinology Vol. 9; no. 10; pp. 1151 - 1158
Main Authors Yoo, Frederick, Soler, Zachary M., Mulligan, Jennifer K., Storck, Kristina A., Lamira, Jensine M., Pasquini, Whitney N., Hill, Jonathan B., Noonan, Tegan E., Washington, Brandon J., Schlosser, Rodney J.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.10.2019
Subjects
Online AccessGet full text
ISSN2042-6976
2042-6984
2042-6984
DOI10.1002/alr.22391

Cover

Loading…
More Information
Summary:Background Olfactory dysfunction (OD) is a common problem, affecting up to 20% of the general population. Previous studies identified olfactory cleft mucus proteins associated with OD in chronic rhinosinusitis (CRS) but not in a healthy population. In this study we aimed to identify olfactory cleft mucus proteins associated with olfaction in individuals without sinus disease. Methods Subjects free of sinus disease completed medical history questionnaires that collected data regarding demographics, comorbidities, and past exposures. Olfactory testing was performed using Sniffin’ Sticks, evaluating threshold, discrimination, and identification. Olfactory cleft mucus (OC) and, in select cases, inferior turbinate mucus (IT) were collected with Leukosorb paper and assays performed for 17 proteins, including growth factors, cytokines/chemokines, cell‐cycle regulators, and odorant‐binding protein (OBP). Results Fifty‐six subjects were enrolled in the study, with an average age of 47.8 (standard deviation [SD], 17.6) years, including 33 females (58.9%). The average threshold/discrimination/identification (TDI) score was 30.3 (SD, 6.4). In localization studies, OBP concentrations were significantly higher in OC than IT mucus (p = 0.006). Cyclin‐dependent kinase inhibitor 2A (CDKN2A/p16INK4a), basic fibroblast growth factor (bFGF), chemokine ligand 2 (CCL2/MCP‐1), granulocyte macrophage colony‐stimulating factor (GM‐CSF), and chemokine ligand 20 (CCL20/MIP‐3a) all inversely correlated with overall TDI (all rho ≥ ‐0.479, p ≤ 0.004). Stem cell factor (SCF) correlated positively with overall TDI (rho = 0.510, p = 0.002). Conclusion Placement of Leukosorb paper is relatively site‐specific for olfactory proteins and it is feasible to collect a variety of olfactory cleft proteins that correlate with olfactory function. Further study is required to determine mechanisms of OD in non‐CRS subjects.
Bibliography:Funding sources for the study: South Carolina Clinical & Translational Research Institute, with an academic home at the Medical University of South Carolina Clinical and Translation Science Award (CTSA); National Institutes of Health/National Center for Advancing Translational Sciences (NIH/NCATS KL2TR001452 and UL1TR001450).
Potential conflict of interest: Z.M.S.: Optinose, Olympus, and Healthy Humming, LLC, consultant; Regeneron and Novartis, advisory board. R.J.S.: Olympus, Sanofi, Optinose, Healthy Humming, LLC, and Stryker, consultant. R.J.S. and Z.M.S.: Entellus, Optinose, Intersect, GSK, Astra Zeneca, Roche, and Sanofi, grant support.
Disclaimer: The contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH or NCATS.
Presented as a podium presentation at Rhinoworld on June 6‐9, 2019, in Chicago, IL.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2042-6976
2042-6984
2042-6984
DOI:10.1002/alr.22391